This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2006 Jan;117(1):26-9.

doi: 10.1016/j.jaci.2005.11.006.

"Black box" warning: wake-up call or overreaction?

Stanley J Szefler, Glenn J Whelan, Donald Y M Leung

PMID: 16387579
DOI: 10.1016/j.jaci.2005.11.006

Editorial

"Black box" warning: wake-up call or overreaction?

Stanley J Szefler et al. J Allergy Clin Immunol. 2006 Jan.

. 2006 Jan;117(1):26-9.

doi: 10.1016/j.jaci.2005.11.006.

Authors

Stanley J Szefler, Glenn J Whelan, Donald Y M Leung

PMID: 16387579
DOI: 10.1016/j.jaci.2005.11.006

No abstract available

PubMed Disclaimer

Comment on

"Black box" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk.
Murphy S, Roberts R. Murphy S, et al. J Allergy Clin Immunol. 2006 Jan;117(1):34-9. doi: 10.1016/j.jaci.2005.10.031. J Allergy Clin Immunol. 2006. PMID: 16387581

Similar articles

"Black box" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk.
Murphy S, Roberts R. Murphy S, et al. J Allergy Clin Immunol. 2006 Jan;117(1):34-9. doi: 10.1016/j.jaci.2005.10.031. J Allergy Clin Immunol. 2006. PMID: 16387581
Primum non nocere and "black box" warnings.
Pearlman DS. Pearlman DS. J Allergy Clin Immunol. 2006 Jan;117(1):30-1. doi: 10.1016/j.jaci.2005.09.030. Epub 2005 Dec 2. J Allergy Clin Immunol. 2006. PMID: 16387580 No abstract available.
Black box warnings-implications in practice.
Zarowitz BJ. Zarowitz BJ. Geriatr Nurs. 2008 Nov-Dec;29(6):402-9. doi: 10.1016/j.gerinurse.2008.09.005. Geriatr Nurs. 2008. PMID: 19064138 No abstract available.
A needed technical fix?
Robertson WO. Robertson WO. Vet Hum Toxicol. 2000 Apr;42(2):118-9. Vet Hum Toxicol. 2000. PMID: 10750184 Review. No abstract available.
Adulteration of drugs and foods: compendial approaches to lowering risk.
Abernethy DR, Sheehan C, Griffiths JC, Williams RL; United States Pharmacopeial Convention Council of Experts Excipients and Food Ingredient Expert Committees. Abernethy DR, et al. Clin Pharmacol Ther. 2009 Apr;85(4):444-7. doi: 10.1038/clpt.2008.88. Epub 2008 May 7. Clin Pharmacol Ther. 2009. PMID: 18463621 Review. No abstract available.

See all similar articles

Cited by

Risk Evaluation and Mitigation Strategies (REMSs): Are They Improving Drug Safety? A Critical Review of REMSs Requiring Elements to Assure Safe Use (ETASU).
Boudes PF. Boudes PF. Drugs R D. 2017 Jun;17(2):245-254. doi: 10.1007/s40268-017-0175-y. Drugs R D. 2017. PMID: 28160230 Free PMC article. Review.
Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma.
Deykin A, Wechsler ME, Boushey HA, Chinchilli VM, Kunselman SJ, Craig TJ, DiMango E, Fahy JV, Kraft M, Leone F, Lazarus SC, Lemanske RF Jr, Martin RJ, Pesola GR, Peters SP, Sorkness CA, Szefler SJ, Israel E; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Deykin A, et al. Am J Respir Crit Care Med. 2007 Feb 1;175(3):228-34. doi: 10.1164/rccm.200601-112OC. Epub 2006 Sep 14. Am J Respir Crit Care Med. 2007. PMID: 16973987 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal